Cargando…

Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment

BACKGROUND: Aromatase inhibitor (AI)-induced joint pain is a common toxicity of AI treatment. Although many studies have been conducted to examine the occurrence and severity of AI-induced joint pain in breast cancer survivors, none of the studies focused on the Chinese population with breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tao, Huang, Yu-Yan, Liu, Xian-Liang, Molassiotis, Alex, Yao, Li-Qun, Zheng, Si-Lin, Tan, Jing-Yu (Benjamin), Huang, Hou-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633515/ https://www.ncbi.nlm.nih.gov/pubmed/36065027 http://dx.doi.org/10.1007/s00520-022-07345-3

Ejemplares similares

Psychometric assessment of the Chinese version of the Oxford Knee Score in breast cancer survivors experiencing hormone treatment-related knee dysfunction
por: Liu, Xian-Liang, et al.
Publicado: (2022)

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
por: Chim, Kannie, et al.
Publicado: (2013)

Yoga versus massage in the treatment of aromatase inhibitor-associated knee joint pain in breast cancer survivors: a randomized controlled trial
por: Tsai, Chia-Lin, et al.
Publicado: (2021)

Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain
por: Nyrop, Kirsten A., et al.
Publicado: (2015)

A qualitative exploration of the unmet information needs of Chinese advanced cancer patients and their informal caregivers
por: Wang, Tao, et al.
Publicado: (2021)

Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
por: Wang, Hai-Ying, et al.
Publicado: (2023)

Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors
por: Wagner, Monica A., et al.
Publicado: (2023)

Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial
por: Liao, Jingwen, et al.
Publicado: (2022)

Feasibility and potential effects of breathing exercise for chronic pain management in breast cancer survivors: study protocol of a phase II randomised controlled trial
por: Wang, Haiying, et al.
Publicado: (2022)

Translation and psychometric testing of the Thai version of cancer survivors’ unmet needs measure among cancer survivors
por: Lekdamrongkul, Pichitra, et al.
Publicado: (2022)

Acupuncture-Point Stimulation for Postoperative Pain Control: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Liu, Xian-Liang, et al.
Publicado: (2015)

What influences aromatase inhibitor continuation intention among breast cancer survivors?
por: Seo, Young Kyung, et al.
Publicado: (2021)

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time
por: Shaaban, Adnan, et al.
Publicado: (2023)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
por: Liu, Lei, et al.
Publicado: (2013)

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019)

Psychometric assessment of the Chinese version of the Problems and Needs in Palliative Care questionnaire-short version in advanced cancer patients
por: Wang, Tao, et al.
Publicado: (2019)

Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor–induced joint pain: a pilot study
por: Martinez, Jessica A., et al.
Publicado: (2021)

The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome
por: Chen, Jie, et al.
Publicado: (2015)

Physical Symptoms, Unmet Needs, and Quality of Life in Thai Cancer Survivors after the Completion of Primary Treatment
por: Pongthavornkamol, Kanaungnit, et al.
Publicado: (2019)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial
por: Mension, Eduard, et al.
Publicado: (2023)

Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Harrigan, Maura, et al.
Publicado: (2021)

Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors
por: Blaes, Anne H., et al.
Publicado: (2023)

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors
por: Fansa, Sima, et al.
Publicado: (2023)

Impact of nonsteroidal aromatase inhibitors on steroid profile in a Chinese population
por: Xing, Yanyi, et al.
Publicado: (2017)

Aromatase inhibitor–associated musculoskeletal pain: An overview of pathophysiology and treatment modalities
por: Grigorian, Nelly, et al.
Publicado: (2022)

Dexmethylphenidate-Induced Rhabdomyolysis by Interaction With Aromatase Inhibitor
por: Huang, Derrick, et al.
Publicado: (2022)

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain: A Randomized Clinical Trial
por: Hershman, Dawn L., et al.
Publicado: (2022)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Modulation of Aromatase by Phytoestrogens
por: Lephart, Edwin D.
Publicado: (2015)

Aromatase in the Human Brain
por: Azcoitia, Iñigo, et al.
Publicado: (2021)

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
por: Mao, Jun J, et al.
Publicado: (2011)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
por: Hong, Yanyan, et al.
Publicado: (2009)

Prevalence and correlates of COVID-19 vaccine hesitancy among Chinese myocardial infarction survivors: A cross-sectional study
por: Lin, Yun, et al.
Publicado: (2023)

Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
por: Honda, Junko, et al.
Publicado: (2011)

Joint association of sedentary behavior and vitamin D status with mortality among cancer survivors
por: Yu, Yu, et al.
Publicado: (2023)

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms
por: Henry, N Lynn, et al.
Publicado: (2021)

Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis
por: Maia, Hugo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kfkukqpoan7ur38hpg4s6jpgah